Macquarie On Cadila HealthO-P, TP Rs 292Disappointed By Quantum Of Payout To CDH Indian Pharma Cos Continue To Struggle With Monetisation Of Specialty MoleculesZypitamag Has Had Slow Ramp-up So Far#CADILAHC